Physician
Primary Care Group LLC
Primary Care Group LLC was paid $23.51M by Medicaid between Jan 2018 and Dec 2024, across 231 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 23% of everything it billed.
33Billing provider infoPRIMARY CARE GROUP LLC
MEMPHIS, TN 38104
MEMPHIS, TN 38104
33aNPI1093016651assigned 11/12/2010
33bProvider typeNeurology Physician
28Total paid$23.51M
24GClaims1,081,150
24DCodes billed231
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Neurology Physician providers in Tennessee
Rank by total paid#1 of 83
Median peer was paid$27K
This provider vs. median887×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 115,293 | $2.58M | |
| 2019 | 149,377 | $3.56M | |
| 2020 | 139,907 | $3.22M | |
| 2021 | 159,107 | $3.94M | |
| 2022 | 163,178 | $3.85M | |
| 2023 | 196,514 | $3.54M | |
| 2024incomplete | 157,774 | $2.82M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 23% | 139,537 | 124,327 | $5.43M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 19% | 145,020 | 121,557 | $4.47M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 14% | 66,805 | 60,461 | $3.30M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 8.5% | 26,762 | 24,972 | $2.00M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 6.4% | 22,440 | 20,116 | $1.50M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.3% | 13,818 | 12,716 | $1.02M |
| 59426 | 2.6% | 7,413 | 4,381 | $606K | |
| 59425 | 2.1% | 6,702 | 5,058 | $504K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.1% | 5,807 | 5,184 | $483K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.5% | 7,450 | 7,047 | $357K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.3% | 9,902 | 6,571 | $298K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.1% | 19,937 | 9,317 | $264K |
219 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.1% | 57,350 | $252K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 18,880 | $222K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 4,384 | $220K |
| 59410 | <1% | 287 | $194K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 2,425 | $140K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,578 | $136K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 3,688 | $120K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 1,714 | $114K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 4,155 | $111K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 3,169 | $88K |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | <1% | 144 | $86K |
| 80050 | General health panel | <1% | 6,969 | $85K |
| 80061 | Lipid panel | <1% | 23,497 | $84K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 2,156 | $83K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 6,638 | $78K |
| 96160 | <1% | 4,113 | $70K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,545 | $62K |
| 80053 | Comprehensive metabolic panel | <1% | 24,394 | $57K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 7,449 | $56K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 4,528 | $47K |
| 99177 | <1% | 5,659 | $46K | |
| 99490 | Ccm add 20min | <1% | 9,025 | $46K |
| 3008F | <1% | 79,871 | $45K | |
| 81025 | <1% | 8,664 | $44K | |
| 96127 | <1% | 8,663 | $38K | |
| 81003 | <1% | 23,735 | $35K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 683 | $35K |
| 92558 | <1% | 6,657 | $34K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 17,817 | $32K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 10,001 | $30K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 371 | $30K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 392 | $28K |
| 36415 | Collection of venous blood by venipuncture | <1% | 13,332 | $25K |
| 90461 | <1% | 38,660 | $21K | |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 301 | $20K |
| 90670 | <1% | 13,989 | $19K | |
| 87807 | <1% | 1,646 | $19K | |
| 83655 | <1% | 1,423 | $19K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 766 | $18K |
| 36416 | <1% | 5,770 | $17K | |
| 82607 | <1% | 3,203 | $14K | |
| 90686 | <1% | 16,876 | $14K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 259 | $13K |
| 76801 | <1% | 237 | $13K | |
| 90651 | <1% | 1,392 | $11K | |
| 82728 | <1% | 2,724 | $11K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 217 | $11K |
| 96161 | <1% | 1,360 | $11K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 204 | $11K |
| 82746 | <1% | 2,492 | $10K | |
| 95819 | <1% | 574 | $10K | |
| 85027 | <1% | 4,566 | $9K | |
| 99439 | <1% | 650 | $8K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,946 | $7K |
| 95822 | <1% | 511 | $7K | |
| 99385 | <1% | 118 | $7K | |
| 83540 | <1% | 4,009 | $7K | |
| 83550 | <1% | 2,819 | $7K | |
| 84439 | <1% | 2,472 | $7K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 2,324 | $7K |
| 82950 | <1% | 2,913 | $6K | |
| 86140 | <1% | 3,681 | $6K | |
| 90716 | <1% | 2,882 | $6K | |
| 80076 | <1% | 2,688 | $6K | |
| 90715 | <1% | 389 | $6K | |
| 90734 | <1% | 820 | $6K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 795 | $6K |
| 99205 | Prolong outpt/office vis | <1% | 80 | $6K |
| 59515 | <1% | 17 | $5K | |
| 99381 | <1% | 66 | $5K | |
| 99383 | <1% | 60 | $5K | |
| 90723 | <1% | 9,965 | $5K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 308 | $5K |
| 90677 | <1% | 1,718 | $5K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 1,291 | $4K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 114 | $4K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 317 | $4K |
| 95816 | <1% | 268 | $4K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 68 | $4K |
| 90707 | <1% | 2,987 | $4K | |
| 95251 | <1% | 411 | $3K | |
| 85652 | <1% | 3,512 | $3K | |
| 90674 | <1% | 534 | $3K | |
| 92551 | <1% | 420 | $3K | |
| 82565 | <1% | 1,952 | $3K | |
| 84480 | <1% | 694 | $3K | |
| 82947 | <1% | 714 | $2K | |
| 99406 | <1% | 541 | $2K | |
| 90680 | <1% | 3,968 | $2K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 16 | $2K |
| 84550 | <1% | 1,697 | $2K | |
| 90647 | <1% | 9,819 | $2K | |
| 86431 | <1% | 1,028 | $2K | |
| 84702 | <1% | 324 | $2K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 130 | $2K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 170 | $1K |
| 99408 | <1% | 478 | $1K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 594 | $1K |
| 99382 | <1% | 24 | $1K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 42 | $1K |
| 84403 | <1% | 290 | $1K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 162 | $1K |
| 90671 | <1% | 1,505 | $1K | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 974 | $1K |
| 82550 | <1% | 654 | $1K | |
| 85014 | <1% | 1,069 | $1K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 186 | $1K |
| 84436 | <1% | 884 | $1K | |
| 85018 | <1% | 1,015 | $1K | |
| 90681 | <1% | 1,317 | $1K | |
| 90633 | <1% | 4,290 | $1K | |
| 90480 | <1% | 28 | $1K | |
| 59025 | Fetal non-stress test | <1% | 31 | $1K |
| 90710 | <1% | 225 | $934.37 | |
| 99441 | <1% | 155 | $851.92 | |
| 83735 | <1% | 564 | $793.03 | |
| 83880 | <1% | 144 | $667.42 | |
| 83690 | <1% | 292 | $659.97 | |
| 84479 | <1% | 665 | $652.82 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 42 | $601.94 |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 27 | $577.61 |
| 87081 | <1% | 175 | $501.06 | |
| 86235 | <1% | 15 | $500.00 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 224 | $480.94 |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 620 | $446.93 |
| 99454 | <1% | 177 | $412.20 | |
| 90474 | <1% | 51 | $354.82 | |
| 82150 | <1% | 152 | $342.03 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 58 | $338.16 |
| 80074 | <1% | 20 | $326.48 | |
| 90656 | <1% | 136 | $291.00 | |
| 84153 | <1% | 67 | $285.00 | |
| 87150 | <1% | 35 | $277.90 | |
| 96380 | <1% | 36 | $268.32 | |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | <1% | 17 | $263.14 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 137 | $259.10 |
| 86803 | <1% | 41 | $237.85 | |
| 90696 | <1% | 245 | $212.26 | |
| 86160 | <1% | 36 | $204.63 | |
| 81001 | <1% | 139 | $195.41 | |
| 82962 | <1% | 399 | $186.68 | |
| 82043 | <1% | 92 | $175.85 | |
| 99457 | <1% | 66 | $174.72 | |
| 85045 | <1% | 194 | $171.23 | |
| 82570 | <1% | 129 | $169.47 | |
| 99497 | <1% | 32 | $158.31 | |
| 73130 | <1% | 74 | $157.98 | |
| 86592 | <1% | 174 | $151.98 | |
| 86225 | <1% | 25 | $151.00 | |
| 3074F | <1% | 3,773 | $140.93 | |
| 3046F | <1% | 1,874 | $140.81 | |
| 90661 | <1% | 71 | $139.92 | |
| 90662 | <1% | 16 | $139.88 | |
| 86038 | <1% | 17 | $135.39 | |
| 86696 | <1% | 15 | $130.46 | |
| 87340 | <1% | 81 | $121.98 | |
| 82533 | <1% | 24 | $112.85 | |
| 3078F | <1% | 3,653 | $110.00 | |
| 99401 | <1% | 16 | $107.10 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 13 | $94.74 |
| 3079F | <1% | 975 | $90.02 | |
| 99397 | <1% | 137 | $85.10 | |
| 3044F | <1% | 14,899 | $80.04 | |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | <1% | 17 | $79.37 |
| 99051 | <1% | 31 | $75.84 | |
| 86695 | <1% | 15 | $73.21 | |
| 90700 | <1% | 171 | $68.66 | |
| 99442 | <1% | 13 | $63.58 | |
| 72170 | <1% | 16 | $47.32 | |
| 86787 | <1% | 39 | $46.36 | |
| 82105 | <1% | 16 | $45.27 | |
| 84460 | <1% | 136 | $39.51 | |
| 84450 | <1% | 136 | $38.51 | |
| 84156 | <1% | 24 | $32.43 | |
| 87511 | <1% | 14 | $31.58 | |
| 80051 | <1% | 19 | $27.80 | |
| 82310 | <1% | 101 | $25.13 | |
| 90688 | <1% | 228 | $20.95 | |
| 86762 | <1% | 41 | $11.66 | |
| 3075F | <1% | 310 | $10.00 | |
| 3045F | <1% | 446 | $10.00 | |
| 82247 | <1% | 125 | $9.74 | |
| 87451 | <1% | 14 | $9.46 | |
| 86850 | <1% | 44 | $7.91 | |
| 84075 | <1% | 124 | $5.18 | |
| 82040 | <1% | 124 | $4.95 | |
| 84155 | <1% | 124 | $3.66 | |
| 84520 | <1% | 94 | $3.56 | |
| 86901 | <1% | 42 | $2.42 | |
| 86900 | <1% | 42 | $2.42 | |
| 84132 | <1% | 83 | $2.18 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 30 | $2.17 |
| 84295 | <1% | 82 | $0.19 | |
| 82374 | <1% | 82 | $0.19 | |
| 82435 | <1% | 82 | $0.17 | |
| 3048F | <1% | 9,815 | $0.04 | |
| 1170F | <1% | 959 | $0.04 | |
| 3049F | <1% | 6,101 | $0.02 | |
| 3292F | 0% | 1,942 | $0.00 | |
| 3052F | 0% | 759 | $0.00 | |
| 90620 | 0% | 55 | $0.00 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 0% | 12 | $0.00 |
| 82952 | 0% | 47 | $0.00 | |
| 3294F | 0% | 57 | $0.00 | |
| 91307 | 0% | 14 | $0.00 | |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 582 | $0.00 |
| 3050F | 0% | 4,801 | $0.00 | |
| 3077F | 0% | 243 | $0.00 | |
| 3051F | 0% | 1,248 | $0.00 | |
| 90685 | 0% | 127 | $0.00 | |
| 90672 | 0% | 17 | $0.00 | |
| 0502F | 0% | 141 | $0.00 | |
| 99072 | 0% | 44 | $0.00 | |
| 90687 | 0% | 59 | $0.00 | |
| 1159F | 0% | 27 | $0.00 | |
| 1160F | 0% | 13 | $0.00 | |
| 54150 | 0% | 16 | $0.00 | |
| 1124F | 0% | 14 | $0.00 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPERRY, TABATHA (MANAGER, PROVIDER ENROLLMENT)
| Provider | Location | Paid |
|---|---|---|
| Methodist Inpatient Physicians LLC | Memphis, TN | $4.83M |
| Specialty Physician Group LLC | Germantown, TN | $3.31M |
| Ut Methodist Physicians LLC | Memphis, TN | $2.68M |
| SPG II LLC | Germantown, TN | $201K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.